The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study
已完结10由 Xinyu Wei 发布于 2025/11/6 20:20:59
DOI:10.1016/j.clbc.2024.01.018
作者:Xi Chen ,?Xinyu Wei ,?Peizhuo Yao ,?Yanbin Liu ,?Haitao Guan ,?Huafeng Kang ,?Di Liu ,?Yan Diao ,?Xiaobin Ma ,?Weili Min ,?Changyou Shan ,?Yang Zhao ,?Fang Zhao ,?Yuanyuan Chen ,?Dong Xiao ,?Qing She
文献类型:期刊论文
补充材料:只需要正文